Xencor Inc (XNCR)

Xencor Inc (XNCR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.9B; returns 1 day -2.6%, 1 week +10.2%, 1 year +104.1%.

Xencor Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing engineered protein therapeutics, primarily monoclonal antibodies and bispecific antibodies, for the treatment of cancer and autoimmune diseases.

Groups XNCR belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Antibody Therapeutics
• Monoclonal Antibodies
• Bispecific Antibodies
• Healthcare
• Oncology
• Autoimmune Diseases
• Life Sciences
• Royalty Streams

XNCR financial model: income statement, cash flow and balance sheet